Sinopharm Group (SHTDF) Stock Price, News & Analysis

Company Overview

Sinopharm Group Co., Ltd. is a China-based healthcare company focused primarily on pharmaceutical and medical product distribution. Through its distribution operations, the company supplies prescription and over-the-counter medicines, medical devices, diagnostic products, vaccines, and other healthcare goods to hospitals, pharmacies, clinics, and other healthcare institutions.

The company also operates pharmaceutical retail businesses and participates in pharmaceutical manufacturing through affiliated operations. Its product portfolio includes medicines and healthcare products across several therapeutic areas, as well as traditional Chinese medicine and medical equipment. Sinopharm serves customers through an extensive distribution and logistics network covering markets throughout mainland China.

Sinopharm Group was established in 2003 and is part of China National Pharmaceutical Group Corporation, commonly known as Sinopharm, a large state-owned healthcare enterprise. Sinopharm Group has been listed on the Hong Kong Stock Exchange since 2009. The company’s operations are principally focused on the Chinese healthcare market, where it provides supply-chain, distribution, retail, and related services to pharmaceutical manufacturers and healthcare providers.

Key Stats

• Today's Range: $2.13 to $2.19
• 50-Day Range: $1.80 to $2.24
• 52-Week Range: $1.72 to $2.70
• Volume: 2,308 shs
• Average Volume: 45,728 shs
• Market Capitalization: N/A
• P/E Ratio: 2.19
• Dividend Yield: 11.87%
• Price Target: N/A
• Consensus Rating: N/A

Sinopharm Group Stock Analysis - MarketRank™

Sinopharm Group scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Sinopharm Group.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sinopharm Group is 2.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.37.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sinopharm Group is 2.19, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.41.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Sinopharm Group has a short interest ratio ("days to cover") of 65.68, which indicates bearish sentiment.

Change versus previous month

Short interest in Sinopharm Group has recently decreased by 66.48%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Sinopharm Group pays a meaningful dividend of 1.11%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Sinopharm Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Sinopharm Group is 26.05%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: N/A

News Sentiment

Sinopharm Group has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Sinopharm Group this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sinopharm Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

16.47% of the stock of Sinopharm Group is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SHTDF
• CIK: 1556605
• Web: www.sinopharmgroup.com.cn
• Phone: 86-21-2305-2666
• Fax: N/A
• Employees: 94,910
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 2.19
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A